FILE PHOTO: A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services clinic in Seattle, Washington, U.S., March 20, 2019. Picture taken March 20, 2019.  REUTERS/Lindsey Wasson/File Photo
A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services clinic in Seattle, Washington. Reuters

Tech firm using counter-extremism software to target ‘anti-vaxxers’




View from London

Your weekly update from the UK and Europe

      By signing up, I agree to The National's privacy policy
      View from London